Buspirone is a serotonin 5-HT1A receptor agonist licensed for the treatment of anxiety. Other anxiolytic drugs such as benzodiazepines show significant sedative and other unwanted effects on cognition. Studies to date have yet to investigate cognitive effects of buspirone using well-validated computerized tests.
The aim of this study was to assess acute subjective and cognitive effects of buspirone in healthy volunteers.
Sixty healthy male volunteers received 20mg buspirone, 30mg buspirone, or placebo per os in a double-blind parallel groups design (N=20 per group). Subjective ratings (visual analogue scales) were completed at baseline, and at 1.5 and 3.5 hours post-capsule. Cognitive assessment was undertaken between 1.5 and 3.5 hours post-capsule, including tests of memory, executive planning, impulse control, decision making and cognitive flexibility.
The 30mg buspirone group showed significantly higher subjective ratings of contentedness 3.5 hours after capsule relative to placebo. Treatment and placebo groups did not differ significantly on cognitive measures.
In contrast to benzodiazepines, the anxiolytic buspirone appears to lack detectable deleterious effects on cognition when administered acutely at clinically meaningful doses. Future research directions are discussed in relation to acute and chronic studies in neuropsychiatric populations.
Aron A R, Fletcher P C, Bullmore E T, Sahakian B J, Robbins T W (2003) Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci6(2): 115–116
2.
Azmitia E C, Gannon P J, Kheck N M, Whitaker-Azmitia P M (1996) Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology14(1): 35–46
3.
Barbee J G, Black F W, Kehoe C E, Todorov A A (1991) A comparison of the single-dose effects of alprazolam, buspirone, and placebo upon memory function. J Clin Psychopharmacol11(6): 351–356
4.
Blackwell A D, Sahakian B J, Vesey R, Semple J M, Robbins T W, Hodges J R (2004) Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord17(1–2): 42–48
5.
Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol47: 211–218
6.
Bond A, Lader M, Shrotriya R (1983) Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG. Eur J Clin Pharmacol24(4): 463–467
7.
Cardinal R N, Aitken M R F (2006) Anova for the Behavioral Sciences Researcher. Lawrence Erlbaum Associates Inc, NJ
8.
Chamberlain S R, Sahakian B J (2005) Neuropsychological assessment of mood disorder. Clin Neuropsych Journ Treat Eval2(3): 137–148
9.
Chamberlain S R, Blackwell A D, Fineberg N, Robbins T W, Sahakian B J (2005) The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev29(3): 399–419
10.
Chamberlain S R, Fineberg N, Blackwell A D, Robbins T W, Sahakian B J (2006a) Motor inhibition and cognitive flexibility in OCD and trichotillomania. Am J Psych Jul 2006
11.
Chamberlain S R, Müller U, Blackwell A D, Clark L, Robbins T W, Sahakian B J (2006b) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science311(5762): 861–863
12.
Charney D S (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry59 (Suppl 14): 11–14
13.
Clark L, Manes F, Antoun N, Sahakian B J, Robbins T W (2003) The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage. Neuropsychologia41(11): 1474–1483
14.
Clark L, Robbins T W, Ersche K D, Sahakian B J (2006) Reflection impulsivity in current and former substance users. Biol Psychiatry
15.
Deakin J B, Aitken M R, Dowson J H, Robbins T W, Sahakian B J (2004a) Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology (Berl)173(1–2): 88–97
16.
Deakin J B, Rahman S, Nestor P J, Hodges J R, Sahakian B J (2004b) Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl)172(4): 400–408
17.
Evenden J L (1999) Varieties of impulsivity. Psychopharmacology (Berl)146(4): 348–361
18.
Goldberg H L (1984) Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy. Pharmacotherapy4(6): 315–324
19.
Goldberg H L and Finnerty R J (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry136(9): 1184–1187
20.
Grasby P M, Friston K J, Bench C, Cowen P J, Frith C D, Liddle P F, Frackowiak R S, Dolan R J (1992a). Effect of the 5-HT1A partial agonist buspirone on regional cerebral blood flow in man. Psychopharmacology (Berl)108(3): 380–386
21.
Grasby P M, Friston K J, Bench C J, Frith C D, Paulesu E, Cowen P J, Liddle P F, Frackowiak R S, Dolan R (1992b) The Effect of Apomorphine and Buspirone on Regional Cerebral Blood Flow During the Performance of a Cognitive Task-Measuring Neuromodulatory Effects of Psychotropic Drugs in Man. Eur J Neurosci4(12): 1203–1212
22.
Hart R P, Colenda C C, Hamer R M (1991) Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry148(1): 73–77
23.
Lezak M D, Howieson D B, Loring D W, Hannay H J, Fischer J S (2004) Neuropsychological Assessment. New York, Oxford University Press
24.
Nelson H E (1982). National Adult Reading Test (NART): Test Manual, Windsor, NFER-Nelson
25.
Owen A M, Sahakian B J, Hodges J R, Summers B A, Polkey C E, Robbins T W (1995) Dopamine-Dependent Frontostriatal Planning Deficits in Early Parkinson's Disease. Neuropsychology9(1): 126–140
26.
Pache D M, Fernandez-Perez S, Sewell R D (2003) Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task. Eur J Pharmacol477(3): 205–211
27.
Rauch S L, Jenike M A (1993) Neurobiological models of obsessive-compulsive disorder. Psychosomatics34(1): 20–32
28.
Robbins T W (2005) Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol493(1): 140–146
29.
Rogers R D, Blackshaw A J, Middleton H C, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin J F, Sahakian B J, Robbins T W (1999) Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl)146(4): 482–491
30.
Roth B L, Hanizavareh S M, Blum A E (2004) Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl)174(1): 17–24
31.
Schaffler K, Klausnitzer W(1989) Placebo-controlled study on acute and subchronic effects of buspirone vs bromazepam utilizing psychomotor and cognitive assessments in healthy volunteers. Pharmacopsychiatry22(1): 26–33
32.
Soubrié P (1986) Reconciling the role of central serotonin neurons in human and animal behaviour. Behav Brain Res9: 319–364
33.
Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer H Y (2001) Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry158(10): 1722–1725
34.
Troisi J R, Critchfield T S, Griffiths R R (1993) Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice. Behav Pharmacol4(3): 217–230
35.
Turner D C, Robbins T W, Clark C, Aron A R, Dowson J, Sahakian B J (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl)165(3): 260–269
36.
Unrug-Neervoort A, van Luijtelaar G, Coenen A (1992) Cognition and vigilance: differential effects of diazepam and buspirone on memory and psychomotor performance. Neuropsychobiology26(3): 146–150
37.
Unrug A, Bener J, Barry R J, van Luijtelaar E L, Coenen A M, Kaiser J (1997a) Influence of diazepam and buspirone on human heart rate and the evoked cardiac response under varying cognitive load. Int J Psychophysiol25(2): 177–184
38.
Unrug A, van Luijtelaar E L, Coles M G, Coenen A M (1997b) Event-related potentials in a passive and active auditory condition: effects of diazepam and buspirone on slow wave positivity. Biol Psychol46(2): 101–111
39.
www.camcog.com. Cambridge Neuropsychological Test Automated Battery (CANTAB), Cambridge Cognition
